WDB coco Co., Ltd. (7079.T)
ValueMarkers Composite Index
87% below intrinsic value ($139)
WDB coco Co., Ltd. (7079.T) — VMCI valuation read
Across 120 indicators, WDB coco Co., Ltd. (7079.T) lands at VMCI 75/100. The Healthcare sector median is 50, so the 25-point above-median read is the active comparison. Pillar weighting on the score: Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%.
No material Form 4 disclosures landed on 7079.T in the past 30 days. Quiet insider tape removes one signal source; the active reads stay with the trailing-twelve-month financials and the next 10-Q.
**Investor frame.** On Value, 7079.T trades at 19.0x earnings, 6% above the Healthcare median of 18.0x; the EV/EBITDA delta of -2.0x reinforces that single line. On Quality, ROIC of 9.0% trails the Healthcare median (10.0%) by 1.0pp. On Risk, net debt to EBITDA of 2.1x is the rate-sensitivity line to watch for 7079.T on the trailing balance sheet.
7079.T fell 1.7% over the trailing 7 days, with a -20.9% read on a 30-day basis.
WDB coco Co., Ltd. provides contract services to pharmaceutical companies in Japan. The company supports the development of pharmaceuticals and medical devices with a focus on safety information management; safety information management support; clinical research support; and post-marketing safety information management operations services. It also provides support for the preparation of various translation, and QC; clinical research support; and manpower dispatch services. In addition, the company offers post-marketing surveillance (PMS) services, such as contract conclusion with medical facilities, survey explanations, receipt of survey forms, monitoring services, including conducting re-surveys, case registration center, data management, and statistical analysis. WDB coco Co., Ltd. was incorporated in 1984 and is headquartered in Tokyo, Japan.
Related Stocks in Healthcare
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.